Diovan HCT 160mg/25mg Tablets

Manufacturer NOVARTIS Active Ingredient Valsartan and Hydrochlorothiazide(val SAR tan & hye droe klor oh THYE a zide) Pronunciation val SAR tan & hye droe klor oh THYE a zide
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.
🏷️
Drug Class
Antihypertensive
🧬
Pharmacologic Class
Angiotensin II Receptor Blocker (ARB) / Thiazide Diuretic Combination
🤰
Pregnancy Category
Category D
FDA Approved
Mar 2000
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Diovan HCT is a combination medicine containing two drugs: valsartan and hydrochlorothiazide. Valsartan helps relax blood vessels, and hydrochlorothiazide helps your body get rid of extra salt and water. Together, they work to lower your blood pressure, which can help prevent strokes, heart attacks, and kidney problems.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow these guidelines:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
You can take your medication with or without food.
Take your medication at the same time every day to establish a routine.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.

Note: This medication may increase your urine production. To minimize sleep disturbances, try to avoid taking it too close to bedtime.

Drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

To ensure the safety and effectiveness of your medication:

Store it at room temperature in a dry place, avoiding the bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your doctor or pharmacist.
If you have questions about disposing of your medication, consult your pharmacist. You may also have access to drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose of your medication:

Take it as soon as you remember.
If it's close to the time for your next dose, skip the missed dose and resume your regular schedule.
* Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take this medication exactly as prescribed, usually once daily, with or without food.
  • Do not stop taking this medication without talking to your doctor, even if you feel well.
  • Continue to follow a low-sodium diet as recommended by your doctor.
  • Engage in regular physical activity and maintain a healthy weight.
  • Limit alcohol intake as it can further lower blood pressure.
  • Avoid potassium supplements or salt substitutes containing potassium unless directed by your doctor.
  • Stay hydrated, especially during exercise or hot weather, but avoid excessive fluid intake unless advised by your doctor.
  • Be aware of potential dizziness, especially when standing up quickly; rise slowly from a sitting or lying position.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: One 160mg/25mg tablet orally once daily
Dose Range: 80 - 320 mg

Condition-Specific Dosing:

hypertension: Initial dose typically 160mg/12.5mg or 80mg/12.5mg once daily, titrated based on blood pressure response. Maximum valsartan dose is 320mg, maximum HCTZ dose is 25mg daily.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
⚕️

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment required (CrCl > 50 mL/min)
Moderate: No dosage adjustment required (CrCl 30-50 mL/min), but monitor renal function closely.
Severe: Contraindicated (CrCl < 30 mL/min) due to the hydrochlorothiazide component.
Dialysis: Contraindicated. Valsartan is not significantly removed by hemodialysis.

Hepatic Impairment:

Mild: No dosage adjustment required.
Moderate: Use with caution; lower initial doses may be considered. Not recommended for severe hepatic impairment or biliary cirrhosis.
Severe: Not recommended.

Pharmacology

🔬

Mechanism of Action

Valsartan selectively blocks the binding of angiotensin II to the AT1 receptor in many tissues, including vascular smooth muscle and the adrenal gland. This inhibits the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation, decreased peripheral resistance, and reduced blood pressure. Hydrochlorothiazide is a thiazide diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule, increasing the excretion of sodium, chloride, and water, and to a lesser extent, potassium and magnesium. This reduces plasma volume and peripheral vascular resistance, contributing to its antihypertensive effect.
📊

Pharmacokinetics

Absorption:

Bioavailability: Valsartan: ~23%; Hydrochlorothiazide: ~65-75%
Tmax: Valsartan: 2-4 hours; Hydrochlorothiazide: 1-2.5 hours
FoodEffect: Valsartan: Food decreases AUC by about 40% and Cmax by about 50%. Hydrochlorothiazide: No clinically significant effect on absorption.

Distribution:

Vd: Valsartan: ~17 L; Hydrochlorothiazide: ~0.8 L/kg
ProteinBinding: Valsartan: ~95% (primarily to serum albumin); Hydrochlorothiazide: ~40-60%
CnssPenetration: Valsartan: Limited; Hydrochlorothiazide: Limited

Elimination:

HalfLife: Valsartan: ~6 hours; Hydrochlorothiazide: 5.6-14.8 hours
Clearance: Valsartan: ~2 L/hr; Hydrochlorothiazide: Renal clearance is ~300 mL/min
ExcretionRoute: Valsartan: Primarily feces (83%) and urine (13%); Hydrochlorothiazide: Primarily urine (95-97% unchanged)
Unchanged: Valsartan: ~13% (urine); Hydrochlorothiazide: 95-97%
⏱️

Pharmacodynamics

OnsetOfAction: Valsartan: Within 2 hours; Hydrochlorothiazide: Within 2 hours
PeakEffect: Valsartan: 4-6 hours; Hydrochlorothiazide: 4-6 hours
DurationOfAction: Valsartan: 24 hours; Hydrochlorothiazide: 6-12 hours

Safety & Warnings

⚠️

BLACK BOX WARNING

When pregnancy is detected, discontinue Diovan HCT as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Signs of fluid and electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Fast or abnormal heartbeat
+ Severe dizziness or passing out
+ Increased thirst
+ Seizures
+ Feeling very tired or weak
+ Decreased appetite
+ Unable to pass urine or change in the amount of urine produced
+ Dry mouth
+ Dry eyes
+ Severe upset stomach or vomiting
Signs of kidney problems, including:
+ Unable to pass urine
+ Change in how much urine is passed
+ Blood in the urine
+ Sudden weight gain
Swelling in the arms or legs
Eye problems, such as:
+ Change in vision
+ Eye pain
These symptoms usually occur within hours to weeks of starting the medication and can lead to permanent vision loss if left untreated.
Skin changes, including:
+ New or changing skin lumps or growths
+ Changes in the color or size of a mole
Protect your skin from the sun and follow your doctor's instructions for regular skin checks.

Other Possible Side Effects

Most people do not experience severe side effects, and some may only have minor side effects. However, if you notice any of the following symptoms or if they bother you or do not go away, contact your doctor or seek medical attention:

Dizziness
Headache
Nose or throat irritation

Reporting Side Effects

This is not a comprehensive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting
  • Swelling of the face, lips, tongue, or throat (signs of angioedema - seek emergency medical help immediately)
  • Difficulty breathing or swallowing
  • Signs of electrolyte imbalance: unusual weakness, muscle cramps, irregular heartbeat, extreme thirst, confusion
  • Signs of kidney problems: little or no urination, swelling in your feet or ankles, feeling tired or short of breath
  • Signs of liver problems: nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes)
  • Unusual skin rash or blistering
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
A known sulfa allergy.
Current or planned use of dofetilide.
Difficulty urinating or inability to pass urine.
Use of a medication containing aliskiren, particularly if you have diabetes or kidney problems.
Breast-feeding, as you should not breast-feed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, avoid driving and other activities that require alertness until you understand how it affects you. To minimize the risk of dizziness or fainting, stand up slowly after sitting or lying down, and exercise caution when climbing stairs.

If you have diabetes, closely monitor your blood sugar levels. Additionally, check your blood pressure as directed by your healthcare provider. Be aware that this medication may cause increases in cholesterol and triglyceride levels. If you already have high cholesterol or triglycerides, discuss this with your doctor.

Regularly have your blood work and other laboratory tests checked as advised by your doctor, as this medication may affect the results of certain lab tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication.

It may take several weeks to experience the full effects of this medication. If you are using a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult with your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor.

Before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products, consult with your doctor.

Also, talk to your doctor before consuming alcohol, marijuana, or other forms of cannabis, or using prescription or OTC drugs that may cause drowsiness. In hot weather or during physical activity, be cautious and drink plenty of fluids to avoid dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these conditions may lead to low blood pressure.

If you are taking cholestyramine or colestipol, consult with your pharmacist about the best way to take these medications with this drug. Be aware of the potential for gout attacks. If you have lupus, this medication may cause your condition to become active or worsen. Immediately report any new or worsening symptoms to your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypotension (low blood pressure)
  • Dizziness or fainting
  • Tachycardia (rapid heart rate)
  • Bradycardia (slow heart rate)
  • Electrolyte disturbances (e.g., hypokalemia, hyponatremia, dehydration)
  • Nausea, vomiting

What to Do:

Seek immediate medical attention or call a poison control center. In the US, call 1-800-222-1222. Treatment is supportive and symptomatic, focusing on stabilizing blood pressure and correcting fluid/electrolyte imbalances.

Drug Interactions

🚫

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment)
  • Potassium supplements or potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride) - due to risk of hyperkalemia
  • Lithium (increased serum lithium levels and toxicity)
🔴

Major Interactions

  • NSAIDs (including selective COX-2 inhibitors) - may reduce antihypertensive effect and increase risk of renal impairment, especially in elderly, volume-depleted, or renally impaired patients.
  • Other antihypertensives (e.g., ACE inhibitors, beta-blockers, calcium channel blockers) - additive hypotensive effects.
  • Digoxin (increased risk of digoxin toxicity due to HCTZ-induced hypokalemia)
  • Corticosteroids, ACTH (enhanced electrolyte depletion, particularly hypokalemia)
  • Pressor amines (e.g., norepinephrine) - possible decreased response to pressor amines.
🟡

Moderate Interactions

  • Antidiabetic agents (oral agents and insulin) - HCTZ may decrease glucose tolerance, requiring adjustment of antidiabetic dosage.
  • Cholestyramine and colestipol resins (may impair absorption of HCTZ)
  • Muscle relaxants, non-depolarizing (e.g., tubocurarine) - enhanced effect due to HCTZ.
  • Alcohol, barbiturates, or narcotics (may potentiate orthostatic hypotension)
  • Allopurinol (increased risk of hypersensitivity reactions with HCTZ)
🟢

Minor Interactions

  • Not available

Monitoring

🔬

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide therapy.

Timing: Before initiation of therapy.

Serum Electrolytes (Potassium, Sodium, Magnesium, Calcium)

Rationale: To assess baseline electrolyte balance, as HCTZ can cause hypokalemia, hyponatremia, hypomagnesemia, and hypercalcemia, and valsartan can cause hyperkalemia.

Timing: Before initiation of therapy.

Renal Function (Serum Creatinine, BUN, eGFR)

Rationale: To assess baseline kidney function, as the drug is contraindicated in severe renal impairment and can affect renal function.

Timing: Before initiation of therapy.

Liver Function Tests (LFTs)

Rationale: To assess baseline liver function, as the drug is used with caution in hepatic impairment.

Timing: Before initiation of therapy.

Serum Uric Acid

Rationale: HCTZ can increase uric acid levels.

Timing: Before initiation of therapy.

Blood Glucose

Rationale: HCTZ can affect glucose metabolism.

Timing: Before initiation of therapy.

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, e.g., weekly initially, then monthly or every 3-6 months once stable.

Target: <130/80 mmHg or individualized target based on patient comorbidities.

Action Threshold: If BP remains elevated despite optimal dosing, consider dose adjustment or additional therapy. If BP is too low, consider dose reduction.

Serum Electrolytes (Potassium, Sodium)

Frequency: Within 1-2 weeks of initiation or dose change, then periodically (e.g., every 3-6 months) or as clinically indicated.

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L

Action Threshold: Potassium <3.0 mEq/L or >5.5 mEq/L; Sodium <130 mEq/L or >150 mEq/L. Address electrolyte imbalances promptly.

Renal Function (Serum Creatinine, eGFR)

Frequency: Within 1-2 weeks of initiation or dose change, then periodically (e.g., every 3-6 months) or as clinically indicated, especially in patients with pre-existing renal impairment or those on concomitant NSAIDs.

Target: Stable creatinine, eGFR > 60 mL/min/1.73m² (or stable for patient's baseline).

Action Threshold: Significant increase in creatinine (>30% from baseline) or decrease in eGFR. Consider dose adjustment or discontinuation if CrCl falls below 30 mL/min.

Serum Uric Acid

Frequency: Periodically, especially in patients with a history of gout.

Target: Within normal limits for the lab.

Action Threshold: Elevated levels, especially if symptomatic (gout flare).

Blood Glucose

Frequency: Periodically, especially in diabetic patients or those at risk for diabetes.

Target: Individualized based on patient's diabetic status.

Action Threshold: Significant hyperglycemia.

👁️

Symptom Monitoring

  • Dizziness or lightheadedness (especially upon standing)
  • Excessive fatigue or weakness
  • Muscle cramps or weakness (signs of electrolyte imbalance)
  • Swelling of face, lips, tongue, or throat (signs of angioedema - rare but serious)
  • Signs of dehydration (e.g., dry mouth, thirst, decreased urination)
  • Unusual bruising or bleeding (rare, due to HCTZ effect on platelets)
  • Yellowing of skin or eyes (jaundice - rare, liver issues)

Special Patient Groups

🤰

Pregnancy

Contraindicated during pregnancy, especially during the second and third trimesters, due to the risk of fetal injury and death (renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death). Discontinue as soon as pregnancy is detected.

Trimester-Specific Risks:

First Trimester: Limited data, but potential risk cannot be excluded. ARBs are generally avoided.
Second Trimester: High risk of fetal injury and death (renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death).
Third Trimester: High risk of fetal injury and death (renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death).
🤱

Lactation

Not recommended during breastfeeding. Both valsartan and hydrochlorothiazide are excreted in human milk. Potential for serious adverse reactions in the breastfed infant (e.g., hypotension, electrolyte disturbances).

Infant Risk: Moderate to High (L3)
👶

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

No overall differences in effectiveness or safety were observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Start with lower doses and monitor renal function and electrolytes closely due to increased risk of renal impairment and electrolyte imbalances in the elderly.

Clinical Information

💎

Clinical Pearls

  • This combination is often used when monotherapy with either valsartan or hydrochlorothiazide is insufficient to control blood pressure.
  • Monitor for signs of angioedema, though rare, it is a serious side effect of ARBs.
  • Patients should be advised to report any signs of electrolyte imbalance (e.g., muscle cramps, weakness, irregular heartbeat).
  • Caution is advised when co-administering with NSAIDs, as this can reduce the antihypertensive effect and increase the risk of renal dysfunction.
  • Due to the HCTZ component, monitor uric acid levels, especially in patients with a history of gout, and blood glucose levels in diabetic patients.
  • Advise patients to avoid sudden changes in position to minimize orthostatic hypotension.
🔄

Alternative Therapies

  • ACE inhibitors (e.g., Lisinopril, Enalapril)
  • Calcium Channel Blockers (e.g., Amlodipine, Nifedipine)
  • Beta-blockers (e.g., Metoprolol, Carvedilol)
  • Other diuretics (e.g., Furosemide, Chlorthalidone)
  • Direct Renin Inhibitors (e.g., Aliskiren - generally not first-line)
💰

Cost & Coverage

Average Cost: Varies widely, typically $30-$150+ per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.